Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Conditions

• Healthy Volunteers (Meningococcal Infection)

Interventions

• BIOLOGICAL: Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine (MenACYW Conjugate vaccine)
• BIOLOGICAL: Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine (MENVEO®)
• BIOLOGICAL: Diphtheria, Tetanus, Acellular Pertussis, Poliovirus and Haemophilus b Vaccine
• BIOLOGICAL: Pneumococcal 13-valent Conjugate Vaccine
• BIOLOGICAL: Rotavirus Vaccine
• BIOLOGICAL: Hepatitis B Vaccine
• BIOLOGICAL: Measles, Mumps, and Rubella Virus Vaccine
• BIOLOGICAL: Varicella Virus Vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company